List of works - Ede Frecska

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity ⬇️

scientific article published on April 26, 2013

Biochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics

scientific article published on 01 October 1984

Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivation.

scientific article

CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.

scientific article published on November 1985

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

scientific article published on 01 January 1985

Dexamethasone suppression test and coping behavior in psychosocial stress ⬇️

scientific article published on February 1, 1988

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

scientific article

Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment

scientific article published on 01 January 1988

Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.

scientific article published in July 2012

Holistic approach in ancient Egypt

scientific article

L-deprenyl in treating negative symptoms of schizophrenia.

scientific article published in May 1992

Perceptional and executive deficits of chronic schizophrenic patients in attentional and intentional tasks.

scientific article published in April 2004

Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells

scientific article published on 29 August 2014

Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca

scientific article

Relapse and insomnia in unipolar major depression

scientific article

Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence.

scientific article published in January 1991

The Dose Reduction in Schizophrenia (DORIS) Study: a final report

scientific article published on 01 January 1997

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization

scientific article

Trazodone--its multifunctional mechanism of action and clinical use

scientific article published on December 1, 2010

Ventricular Enlargement in Poor-Outcome Schizophrenia ⬇️

scientific article published on June 1, 1998

List of works by Ede Frecska

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity ⬇️

Biochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics

Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivation.

CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

Dexamethasone suppression test and coping behavior in psychosocial stress ⬇️

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment

Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.

Holistic approach in ancient Egypt

L-deprenyl in treating negative symptoms of schizophrenia.

Perceptional and executive deficits of chronic schizophrenic patients in attentional and intentional tasks.

Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells

Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca

Relapse and insomnia in unipolar major depression

Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence.

The Dose Reduction in Schizophrenia (DORIS) Study: a final report

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization

Trazodone--its multifunctional mechanism of action and clinical use

Ventricular Enlargement in Poor-Outcome Schizophrenia ⬇️

['Hit and run': The old paradigm of psychopharmacology in a new coat' - Editorial]

[Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review]

[Changes in the brain with schizophrenia: postmortem findings]

[Maintenance therapy in schizophrenia -- a brief review of the literature]

[Psychomanteum: Ancient walk to our unconscious]